Altrinsic Global Advisors’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-70,000	Closed	-$10.7M	–	84
2021 Q1	$10.7M	Hold	70,000	–	–	0.34%	45
2020 Q4	$10.9M	Hold	70,000	–	–	0.37%	42
2020 Q3	$8.01M	Hold	70,000	–	–	0.33%	42
2020 Q2	$7.86M	Sell	70,000 -5,000	-7%	-$531K	0.34%	39
2020 Q1	$6.73M	Buy	75,000 +10,000	+15%	+$981K	0.37%	40
2019 Q4	$7.03M	Hold	65,000	–	–	0.3%	40
2019 Q3	$6.37M	Hold	65,000	–	–	0.28%	43
2019 Q2	$8.51M	Hold	65,000	–	–	0.39%	41
2019 Q1	$8.79M	Hold	65,000	–	–	0.41%	42
2018 Q4	$6.33M	Buy	65,000 +5,000	+8%	+$591K	0.3%	44
2018 Q3	$8.34M	Buy	60,000 +10,000	+20%	+$1.25M	0.38%	41
2018 Q2	$6.21M	Hold	50,000	–	–	0.25%	44
2018 Q1	$5.57M	Buy	50,000 +5,000	+11%	+$598K	0.23%	43
2017 Q4	$5.38M	Buy	45,000 +20,000	+80%	+$2.44M	0.21%	46
2017 Q3	$3.51M	Sell	25,000 -5,000	-17%	-$679K	0.13%	59
2017 Q2	$3.65M	Buy	+30,000	New	+$3.49M	0.13%	62